NHSc

Nestlé successfully completed acquisition of Aimmune Therapeutics

THE FINANCIAL -- Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. (Nasdaq: AIMT). Joining Nestlé…

2 years ago